Less than two years after…
Less than two years after emerging, Arena BioWorks is shuttering, [...]
Less than two years after emerging, Arena BioWorks is shuttering, [...]
The companies and federal officials are engaged in talks and [...]
Even without accounting for the COVID-related declines that have punctuated [...]
Pfizer has axed 11 programs including two pipeline assets from [...]
Questex has acquired The Conference Forum and Versalinx Global Events, [...]
Eli Lilly is going for gold at the Milano Cortina [...]
President Trump wants pharmaceutical production to return to the United [...]
Neurology-focused patient groups’ perception of the pharma industry’s corporate reputation [...]
Kimberly-Clark has placed an ambitious bet on a troubled counterpart, [...]
Tempero Bio has hit the brakes on a phase 2-stage [...]